A research team at the Korea Institute of Science and Technology (KIST), in partnership with Seoul National University (SNU) and Kyung Hee University, developed a new drug delivery system that could better treat retinal diseases.Retinal diseases, such as age-related macular degeneration and retiniti
Merck Korea said it launched its Fertility Benefit Program for its employees and their spouses, effective from Jan. 1 this year.Merck Korea has about 1,750 employees, according to its website. The program, part of Merck's broader initiative "Fertility Counts," is designed to support the reproductive
Lotte Biologics said it has entered into a strategic partnership with NJ Bio, a U.S. contract research organization (CRO), to enhance antibody-drug conjugate (ADC) services.Established in 2018 and based in New Jersey, NJ Bio specializes in integrated chemical and biological services for linker paylo
Korea is currently facing a significant ethical and legal dilemma in its medical sector due to increasing instances of doctors performing surgeries while under the influence of alcohol.This issue gained national attention following an incident in January, where a young surgeon in Seoul conducted fac
GC Biopharma said that the intracerebroventricular (ICV) enzyme replacement therapy (ERT) drug for Sanfilippo Syndrome Type A, jointly developed with Korean biotech venture Novel Pharma, has been designated as an orphan drug by the European Medicines Agency (EMA).The recognition follows the drug's p
Nestled in the Eunpyeong-gu, northwestern Seoul, Eunpyeong St. Mary's Hospital has become an important center for healthcare and community service as it approaches its fifth anniversary.Established to deliver comprehensive medical care, the hospital is particularly known for cardiac care, neurology,
Dongwha Pharm said it acquired four over-the-counter (OTC) products from Celltrion, which the latter purchased from Takeda Pharmaceuticals in 2020, for about 37.2 billion won ($27.8 million).The transaction includes medications such as the comprehensive cold medicine Whituben and Whituben Nasal Spra
CanariaBio said the Data and Safety Monitoring Board (DSMB) recommended halting its global phase 3 clinical trial of oregovomab, an antibody targeting CA125, for ovarian cancer patients.The company said that the recommendation was made due to the trial not achieving the necessary statistical value (
Lunit said its AI-powered chest screening solution, Lunit INSIGHT CXR, outperformed its competitors in a study comparing seven AI chest screening solutions.The research was conducted by the Project AI for Radiology team at Radboud University Medical Center in the Netherlands, led by Professor Kicky
As Korea grapples with an aging population, gastric cancer is becoming a huge concern as it remains the fourth most common cancer in the country.A significant portion of gastric cancer cases are diagnosed in older adult patients, with recent statistics from the National Health Insurance Service reve
EuBiologics said it will prematurely terminate the phase 3 clinical trials of EuCorVac-19, its Covid-19 vaccine.In January 2022, EuBiologics had received approval from the Ministry of Food and Drug Safety for the phase 3 trial plan of the vaccine.However, the company decided to end the trial due to
Prestige Biologics said it has signed a contract manufacturing organization (CMO) agreement with Celltrion for the latter's clinical materials, amounting to 9 billion won ($6.6 million).This contract represents a 522 percent increase over the previous year's revenue of 1.7 billion won, quintupling t
Korea's diabetes management landscape is experiencing a transformation with the increased use of continuous glucose monitoring (CGM) systems and advanced artificial pancreas technologies.This shift, particularly impactful for pediatric type 1 diabetes patients, was a focal point in a recent media ed
A Seoul National University Hospital (SNUH) team has proposed prospects for the treatment of various forms of hair loss, including androgenetic alopecia.Androgenetic alopecia, one of the most common types of hair loss worldwide, occurs due to hormonal, genetic, or environmental factors that thin the
Celltrion said it launched the 80mg/0.8mL dosage form of Yuflyma, a biosimilar referencing Abbvie's Humira (ingredient: adalimumab), in the U.S.Humira, the original medicine, is prescribed primarily for autoimmune diseases such as rheumatoid arthritis, inflammatory bowel disease, and psoriasis. Yufl
The U.S. Food and Drug Administration (FDA) has declared the recall of continuous positive airway pressure (CPAP) masks by global sleep solution company ResMed as a significant matter related to patients' lives.The FDA said last Thursday that the ResMed CPAP mask recall incident, which occurred last
Hanmi Science, the holding company of Hanmi Pharm, announced a significant restructuring, welcoming OCI Group as its major shareholder and establishing a joint management system.The move, made public on Saturday last week, was a surprise to many, including Hanmi Pharm CEO Lim Jong-yoon, who expresse
SAN FRANCISCO, Calif. -- By Lee Han-soo/Korea Biomedical Review correspondent -- GC Cell, a notable player in the biotechnology field, is increasingly making its mark in the area of cell and gene therapy (CGT).Under the guidance of CEO James Park, who was appointed in March 2023, the company is acti
SAN FRANCISCO, Calif. -- By Lee Han-soo/Korea Biomedical Review correspondent -- Seo Jin-seok, Celltrion Group Founder and co-Chairman Seo Jung-jin's eldest son and co-Chairman of the Board of Directors of Celltrion, made his first international conference debut on Wednesday at the J.P. Morgan Healt
SAN FRANCISCO, Calif. -- By Lee Han-soo/Korea Biomedical Review correspondent --Celltrion Group Founder and Co-Chairman Seo Jung-jin promised that the company will continue to develop and manufacture biosimilars until all seven billion people in the world have access to affordable treatments.Speakin